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Upper- versus lower-limb aerobic exercise training
on health-related quality of life in patients with
symptomatic peripheral arterial disease
John M. Saxton, PhD,a Irena Zwierska, PhD,b Milisa Blagojevic, PhD,b Sohail A. Choksy, PhD,c
Shah Nawaz, MD,d and A. Graham Pockley, PhD,e Norwich, Keele, Colchester, and Sheffield, United Kingdom
Objective: This randomized controlled trial investigated the effects of upper- and lower-limb aerobic exercise training on
disease-specific functional status and generic health-related quality of life (QOL) in patients with intermittent claudication.
Methods: The study recruited 104 patients (mean age, 68 years; range, 50-85) from the Sheffield Vascular Institute. Patients
were randomly allocated to groups that received upper-limb (ULG) or lower-limb (LLG) aerobic exercise training, or to a
nonexercise control group. Exercise was performed twice weekly for 24 weeks at equivalent limb-specific relative exercise
intensities. Main outcome measures were scores on the Walking Impairment Questionnaire (WIQ) for disease-specific
functional status, theMedical Outcomes Study Short Form version 2 (SF-36v2), and EuropeanQuality of Life Visual Analog
Scale (EQ-VAS) for health-related QOL. Outcomes were assessed at baseline, and at 6, 24, 48, and 72 weeks.
Results: After 6 weeks, improvements in the perceived severity of claudication (P  .023) and stair climbing ability (P 
.011) vs controls were observed in the ULG, and an improvement in the general health domain of the SF-36v2 vs controls
was observed in the LLG (P .010). After 24 weeks, all four WIQ domains were improved in the ULG vs controls (P<
.05), and three of the four WIQ domains were improved in the LLG (P < .05). After 24 to 72 weeks of follow-up, more
consistent changes in generic health-related QOL domains were apparent in the ULG.
Conclusions:These findings support the use of alternative, relatively pain-free forms of exercise in the clinical management
of patients with intermittent claudication. (J Vasc Surg 2011;53:1265-73.)
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wIntermittent claudication is a chronic disabling condi-
tion in the elderly that can lead to a significant impairment
in heath-related quality of life (QOL). Population surveys
have reported an approximate prevalence of 5% in those
aged between 55 and 74 years.1,2 However, the prevalence
of asymptomatic peripheral arterial disease (potentially
causing disruption to lower-limb blood flow) is reported to
progressively increase from 3% at60 years of age to20%
in those aged 75 years.3 Although health-related QOL
decrements in patients with intermittent claudication are
primarily related to physical limitations and pain,4-6 they
can also include reductions in social, emotional, andmental
well-being.7-9
Lower-limb exercise, such as walking, has consistently
been shown to improve pain-free and maximum walk-
ing distances10 and can lead to improvements in disease-
specific and generic health-related QOL domains.11-16
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doi:10.1016/j.jvs.2010.10.125owever, a significant proportion of patients refrain from
ngaging in walking exercise,17 and evidence suggests that
elf-reported walking ability declines at a rate of 9.2 yards
8.41 meters) per year.18 The degree of ischemic pain evoked
y walking probably deters some patients from engaging in
hysical activity, and this could contribute to subsequent
isability and the enhanced risk of cardiovascular morbidity
nd mortality that is observed in this patient group.19
Alternative exercise strategies that can reduce or pre-
ent the ischemic pain that is associated with lower-limb
eight-bearing exercise, such as walking, could help to
vercome the barriers to conventional forms of exercise
ehabilitation in these patients. Upper-limb aerobic exer-
ise training (arm-cranking exercise) avoids the ischemic
ain experienced during lower-limb exertion20 and evokes
imilar improvements in walking performance in claudi-
ants as that induced by lower-limb cycle ergometry exer-
ise.21,22 However, the relative effect of body weight-
upported upper-limb and lower-limb aerobic exercise
raining on disease-specific and generic health-relatedQOL
utcomes has not previously been investigated.
Hence, the aim of this study was to compare the
elative effects of a 6-month program of body weight-
upported upper-limb and lower-limb aerobic exercise
raining on patients’ perceptions of disease-specific func-
ional status and generic health-related QOL. Because
ourse of changes over time in these health outcomes
uring exercise rehabilitation is poorly understood, both
he short-term (6 weeks) and longer-term (up to 72
eeks of follow-up) effects of exercise rehabilitation
ere studied. To our knowledge, this is the first study to
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May 20111266 Saxton et alreport longer-term changes in disease-specific and generic
QOL outcomes after upper-limb and lower-limb aerobic ex-
ercise rehabilitation in patients with symptomatic peripheral
arterial disease.
METHODS
The North Sheffield Local Research Ethics Committee
approved this study. All patients gave their informed con-
sent before entering the study.
Patient recruitment. A total of 537 patients with
Fig 1. Flow of partiintermittent claudication attending the Sheffield Vascular mnstitute at the Northern General Hospital, Sheffield,
nited Kingdom, were approached, of whom 130 agreed
o attend prescreening. Of these, 104 patients (81 men, 23
omen) with a mean age of 68 years (range, 50-85) years
ere randomized (Fig 1).
The clinical diagnosis of peripheral arterial disease was
stablished using the patient’s history and a physical exam-
nation and was confirmed by the Doppler assessment of
nkle-brachial pressure index (ABPI, 0.9). The study
xcluded patients who had experienced symptoms for12
ts through the trial.onths, had undergone a revascularization procedure12
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Volume 53, Number 5 Saxton et al 1267months of recruitment, or had exercise-limiting angina,
shortness of breath, or severe arthritis.
No patients were taking medication for claudication
during the course of this study, but patients taking long-
term medication continued with their treatment. Most
patients were taking statins and aspirin in accordance with
guidelines for patients with intermittent claudication.
Some patients were also taking -blockers, angiotensin-
converting enzyme inhibitors, calcium-channel blockers,
nitrates, diuretics, or warfarin. Medication was generally
well balanced across the groups.
Patient randomization. A fishbowl technique was
used to randomly assign patients to groups that received
upper-limb (ULG; n  34) or lower-limb (LLG; n  37)
aerobic exercise training, or to a nonexercise control group
(n  33). Randomization was undertaken by a member of
the research team (A.G.P.), who was located at a different
site and was not directly involved in the recruitment or
assessment of patients. The randomization sequence was
not disclosed to the researcher who was responsible for the
day-to-day running of the trial (I.Z.) until patients had
completed their baseline assessments. Baseline demo-
graphic characteristics of the three groups are presented in
Table I.
Exercise interventions. Patients in the exercise
groups performed twice-weekly supervised exercise train-
ing at equivalent relative exercise intensities (85% to 90% of
the limb-specific peak oxygen consumption) for 24 weeks,
using an arm-cranking or leg-cycling ergometer (881E arm
crank and 824E cycle ergometer, Monark, Varberg, Swe-
den). The frequency of exercise training was based on pilot
work with the patients and a frequency that was likely to
Table I. Baseline characteristics of the three study groups
Variablea ULG (n  34)
Age, years 68 (54-84)
Body weight, kg 80.8  1.9
Height, meters 1.68  0.01
Body mass index, kg/m2 28.6  0.7
Sex
Male 27 (79)
Female 7 (21)
Resting ABPI 0.65  0.03
Duration of claudication, months 50  8
Angina 6 (18)
Previous MI 3 (9)
Previous stroke 6 (18)
Diabetes mellitusd 6 (18)
Smoking status
Current 8 (24)
Previous 25 (73)
Never smoked 1 (3)
ABPI, Ankle-brachial pressure index (reported for the most symptomatic
between the groups; ULG, upper-limb group.
aContinuous values are presented as the means  standard error or as medi
bAnalysis of variance.
c2 test.
dPatients with diabetes mellitus were taking oral hypoglycemics or insulin.result in good compliance. In practice, a very flexible ap- froach was needed to ensure that patients attended both
eekly sessions.
Patients exercised in cycles of 2 minutes of exercise at a
rank rate of 50 rpm, followed by 2 minutes of rest for a
otal exercise time of 20 minutes in a 40-minute session.
ncremental arm-cranking and leg-cranking tests to maxi-
um exercise tolerance were performed during weeks 6,
2, and 18 of the intervention so that the respective upper-
imb and lower-limb exercise intensities could be adjusted
o ensure progression of the exercise stimulus. Heart rate
nd pulmonary gas exchange variables (PulmoLab EX670,
organ Medical, Kent, UK) were continuously monitored
uring these assessments, and perceived exertion was as-
essed during each increment using the Borg Ratings of
erceived Exertion scale.23
Outcome measures. Walking performance, disease-
pecific functional status, and health-related QOL were
ssessed at baseline and after 6, 24, 48, and 72 weeks of follow-
p. Questionnaire outcomes were self-administered, and re-
ponseswere checked for completeness by the researcher (I.Z.)
n the presence of the patient. Assessment procedures were
hecked for consistency at random by the lead investigator
t SheffieldHallamUniversity (J.M.S.), whowas blinded to
roup assignment.
Walking performance. Walking performance was as-
essed using an incremental shuttle-walk test, as described
reviously.21 This can be used in the clinical setting, with-
ut the need for an expensive programmable treadmill, to
ssess walking performance. It exhibits similar test–retest reli-
bility as treadmill testing, evokes a lower level of cardiovascu-
ar stress, and is preferred to treadmill testing by a large
roportion of patients.24 Briefly, patients walked back and
LLG (n  37) Controls (n  33) P
68 (50-85) 71 (56-84) NSb
76.3  2.2 78.3  3.2 NSb
1.69  0.01 1.67  0.01 NSb
26.6  0.6 27.8  1.0 NSb
NSc
30 (81) 24 (73)
7 (19) 9 (27)
0.64  0.03 0.69  0.03 NSc
59  9 55  7 NSc
5 (14) 8 (24) NSc
1 (3) 4 (12) NSc
7 (19) 5 (15) NSc
3 (8) 9 (27) .05c
NSc
14 (38) 11 (33)
20 (54) 20 (61)
3 (8) 2 (6)
; LLG, lower-limb group; MI, myocardial infarction; NS, no significance
ge), and continuous values are No (%).limb)
an (ranorth between two cones placed 10meters apart on a flat floor.
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audiotape. The distance walked before the onset of claudica-
tion pain (claudication distance) and the maximum walking
distance (MWD), which was achieved before the test was
terminated due to intolerable claudication pain, were calcu-
lated.
Disease-specific functional status. The Walking Im-
pairment Questionnaire (WIQ) is a disease-specific ques-
tionnaire that asks a series of questions regarding a patient’s
self-reported claudication severity and ability to walk defined
distances and speeds, in addition to perceived stair climbing
ability.25 A score of 0% represents very severe claudication pain
Fig 2. Effects of upper-limb and lower-limb aerobic exe
distance (adjusted for baseline values). Data are presen
confidence intervals. **P  .001 relative to the control
Table II. Baseline measurements and outcomes for the th
Variablea
ULG
(n  34)
MWD 321  29
CD, meters 101 (25-430)
SF-36v2
Physical functioning 46.8  3.5
Role–physical 53.9  4.2
Bodily pain 50.9  3.4
General health 56.8  3.3
Vitality 53.5  2.9
Social functioning 79.4  4.2
Role–emotional 70.1  5.4
Mental health 78.1  2.9
EuroQol 68.4  2.5
WIQ
Calf pain 47.1  4.0
Walking distance 35.8  5.6
Walking speed 38.2  4.4
Stair climbing 45.6  4.8
CD, Claudication distance; EuroQoL, European Quality of Life assessment;
between the groups; SF-36v2, Medical Outcomes Study Short Form version
aValues are presented as means  SE or median (range).
bAnalysis of variance.
cMann-Whitney U test.or very poor ability in relation to the domains of walking Tistance, walking speed, and stair climbing, and a score of
00% represents no claudication pain and high physical ability
n relation to the three other domains. TheWIQ distance and
peed scores correlatewith treadmill walking performance and
re responsive to exercise training in patients with intermittent
laudication.12,13,26
Generic health-related QOL assessment. Generic
ealth-related QOL was assessed using the British version
f the Medical Outcomes Study Short-Form (SF-36v2)27
nd the second part of the European Quality of Life (Euro-
ol) Visual Analog Scale instrument (EQ-VAS).28 The SF-
6v2 contains 36 questions covering eight health domains.
training relative to the control group on maximum walk
as mean differences, with error bars representing 95%
.
tudy groups
LLG Controls
P(n  37) (n  33)
337  22 297  24 NSb
85 (20-568) 98 (28-408) NSc
48.8  3.2 46.1  4.1 NSb
56.4  4.9 53.6  4.9 NSb
53.2  3.8 51.1  3.4 NSb
54.0  3.2 49.7  3.2 NSb
50.3  3.5 48.7  3.2 NSb
76.0  4.0 76.5  4.7 NSb
70.7  5.2 77.0  4.2 NSb
72.6  3.3 77.4  2.5 NSb
66.2  2.9 64.8  2.6 NSb
41.9  2.9 49.2  3.5 NSb
35.2  4.5 31.5  5.2 NSb
36.5  3.4 36.7  4.1 NSb
49.7  4.8 44.8  5.7 NSb
lower-limb group; MWD, maximum walking distance; NS, no significance
LG, upper-limb group; WIQ, Walking Impairment Questionnaire.rcise
tedree s
LLG,
2; Uhe score for each response was coded and transformed to
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for each QOL domain to produce a health profile. Most of
the eight SF-36v2 domains are significantly correlated with
the WIQ speed, distance, and stair climbing indexes for
patients with intermittent claudication.29 The EuroQol is a
simple health status instrument that is specifically designed
to complement other QOL measures. The graduated 100-
point EQ-VAS was used to rate the current health state of
the patient, with 100 indicating the best imaginable health
state, and 0 indicating the worst imaginable health state.
Sample size calculation. The primary outcome vari-
able for the calculation of sample size was walking perfor-
mance, as defined by the MWD. In a preliminary study,
MWD increased from amean baseline level of 289 127 to
427  219 meters after a 6-week period of upper-limb
Fig 3. Effects of upper-limb and lower-limb aerobic ex
Impairment Questionnaire domains. Data are present
confidence intervals. *P  .05 relative to the control gro
Table III. Effects of upper-limb and lower-limb aerobic e
Group (vs
controls)
6 weeks, meters
P
24 weeks, meters
Mean difference Mean difference
(95% CI) (95% CI)
ULG 21.59 (2.24 to 40.93) .072 52.37 (28.16 to 76.59
LLG 12.25 (–6.64 to 31.14) .753 44.41 (21.56 to 67.26
CI, Confidence intervals; LLG, lower-limb group; ULG, upper-limb group.
aValues are mean differences with 95% CI (adjusted for baseline values). Beaerobic exercise training.21 The improvement inMWDwas cccompanied by significant improvements in the physical
unctioning and role limitation-physical quality QOL do-
ains. On the basis of these data, and taking into account
n expected patient dropout of 30% over a 6-month inter-
ention period, recruitment of 35 patients for each group
ielded an 80% power to detect a meaningful improvement
n MWD at the   0.05 level.
Statistical methods. Intention-to-treat analysis was
sed to compare patients in the groups to which they were
andomly assigned, with data being carried over from pre-
ious visits in cases of patient withdrawal. Changes in the
ependent variables (MWD, WIQ, SF-36v2 and EQ-VAS)
ver time within groups and differences between groups at
he same time points were evaluated using repeated-measures
nalysis of variance with corresponding post hoc Bonferroni
training relative to the control group on the Walking
mean differences, with error bars representing 95%
*P  .01 relative to the control group.
se training relative to controls on claudication distancea
48 weeks, meters
P
72 weeks, meters
P
Mean difference Mean difference
(95% CI) (95% CI)
5 48.15 (26.67 to 69.63) .038 47.94 (27.61 to 68.27) .041
4 35.58 (11.49 to 59.67) .049 37.92 (14.08 to 61.75) .046
the data were nonnormally distributed, bootstrap P values are reported.ercise
ed asxerci
P
) .03
) .04orrected t tests. Data distributions were relatively asym-
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bootstrapping with 1000 replicates was performed. The
results based on the normality assumption were reliable,
with the exception of claudication distance.
Data were analyzed blindly by a statistician (M.B.) who
was not involved in the day-to-day running of the trial
using Stata 9 software (StataCorp LP, College Station,
Tex) are reported as mean values standard error or mean
differences between the exercise groups and controls, with
95% confidence intervals (CIs). Statistical significance was
assumed at P  .05.
RESULTS
Baseline characteristics of the study groups, patient
compliance, and attrition. The study groups were well
matched on demographic, walking performance,WIQ, and
generic health-related QOL variables at baseline (Tables I
and II). Compliance to the supervised upper-limb and
lower-limb exercise sessions was excellent (about 99%), and
this was achieved by offering a flexible weekly exercise
schedule. Of the 104 patients randomized, 3 withdrew
before the 6-week assessment, 7 patients withdrew before
the end of the 24-week intervention, and 15 patients with-
drew during the 48- to 72-week follow-up period (Fig 1).
No serious adverse events related to the assessments or
exercise training were reported.
Walking performance. Similar improvements in
walking performance were observed in the two exercising
groups at all follow-up evaluations. The mean difference in
MWD (in meters) between the exercising groups and con-
trols at 6 weeks was 54.03 (95% CI, 36.07-71.98) for the
ULG and 53.81 (95% CI, 31.21-76.40 m) for the LLG, and
Table IV. Effects of upper-limb and lower-limb aerobic e
Outcomes Study Short Form 36 version 2 (SF-36 v2) dom
SF-36 v2 domain
Group (vs
controls)
Mean diffe
(95% C
Physical functioning ULG 1.40 (–6.38 to
LLG 4.40 (–1.26 to
Role–physical ULG –6.48 (–16.33
LLG 1.00 (–6.94 to
Bodily pain ULG 3.32 (–5.42 to
LLG 3.29 (–4.82 to
General health ULG 2.65 (–4.54 to
LLG 8.44 (2.13 to
Vitality ULG –0.11 (–5.94 to
LLG 0.93 (–5.04 to
Social functioning ULG –0.80 (–10.33
LLG 3.17 (–5.88 to
Role–emotional ULG 0.76 (–10.60
LLG –1.99 (–11.37
Mental health ULG 0.95 (–4.80 to
LLG 2.34 (–3.45 to
LLG, Lower-limb group; ULG, upper-limb group.
aNegative mean difference value indicates lower than the control group.
bP value indicates significant difference from the control group.at 24 weeks was 94.72 (95% CI, 69.85-119.58) for the ULG hnd 113.89 (95% CI: 83.28-144.50) for the LLG (all P 
001; Fig 2). At 48 and 72weeks, the improvements inMWD
n the exercising patients vs control group were maintained
P  .001; Fig 2). There was no difference between the
mprovements in the ULG and LLG at any time point. A
ustained improvement in claudication distance was also ob-
erved in exercising patients vs the controls (Table III). No
hange in the ankle-brachial pressure index was apparent in
ither exercise group (data not shown).
Short-term effects of exercise on patient-assessed
ealth outcomes (6 weeks). Improvements in perceived
laudication severity (P  .02) and stair climbing ability
P .01) vs the controls only occurred in the ULG after 6
eeks (Fig 3). An improvement in the general health
omain of the SF-36v2 was also observed in the LLG
ompared with the controls (Table IV). No other differ-
nces were observed in any of the WIQ, SF-36v2 or EQ-
AS domains after 6 weeks of the intervention.
The longer-term effects of exercise onpatient-assessed
ealth outcomes (24 weeks). Improvements in the sever-
ty of claudication pain, walking speed, and stair climbing
bility in relation to controls were observed in both exercise
roups at 24 weeks (P  .05; Fig 3). An improvement in
he walking distance domain of the WIQ was also observed
n the ULG vs controls (P  .01). In the ULG, elevated
evels of the physical function, bodily pain, general health,
itality, and mental health domains of the SF-36v2 vs
ontrols were also observed (Table IV).
A trend for improvement in the EQ-VAS vs controls
as observed in the ULG at 24 weeks, with a mean differ-
nce between ULG and controls of 6.13 (95% CI, –0.32 to
2.58; P  .06). In the LLG, higher levels of the general
se training relative to controls group on the Medical
(adjusted for baseline values)a
ks 24 weeks
P
Mean difference
(95% CI) P
) .244 12.28 (5.44 to 19.12) .001b
6) .125 6.25 (–0.14 to 12.65) .055
7) .193 1.47 (–7.20 to 10.14) .736
) .803 2.35 (–5.59 to 10.30) .556
5) .451 11.42 (3.40 to 19.44) .006b
9) .421 0.64 (–7.31 to 8.58) .874
) .464 7.32 (0.39 to 14.26) .039b
) .010b 9.18 (3.39 to 14.96) .002b
) .970 7.56 (1.33 to 13.80) .018b
) .757 6.54 (0.48 to 12.59) .035b
3) .867 3.61 (–5.76 to 12.98) .445
2) .487 –1.72 (–11.15 to 7.71) .717
.12) .894 5.09 (–6.43 to 16.60) .381
9) .673 7.78 (–2.41 to 17.96) .132
) .742 7.61 (1.39 to 13.94) .017b
) .423 5.02 (–1.05 to 11.09) .104xerci
ains
6 wee
rence
I)
9.19
10.0
to 3.3
8.94
12.0
11.3
9.85
14.76
5.72
6.91
to 8.7
12.2
to 12
to 7.3
6.70
8.12ealth and vitality domains of the SF-36v2 vs controls were
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EQ-VAS, with a mean difference between LLG and con-
trols of 4.69 (95% CI, –0.97 to 10.34; P  .10).
At 48 to 72 weeks of follow-up, the improvements in
perceptions of walking distance were better maintained in
the ULG than in the LLG. The improvements in walking
speed and stair climbing ability were similarly maintained in
both exercising groups (Fig 3).
Sustained improvements in SF-36v2 domains were also
observed during the longer-term follow-up period, although
these did not always reach statistical significance (Table IV).
HigherEQ-VAS scores (meandifference, 7.85-8.46;P .03)
in both exercising groups vs controls were observed at 48 to
72 weeks.
DISCUSSION
This study investigated the short-term and longer-term
effects of body weight-supported upper-limb and lower-limb
aerobic exercise training on self-perceived disease-specific
functional status and generic health-related QOL in patients
with intermittent claudication.We observed excellent compli-
ance with both exercise regimens, though our recruitment
rate of about 20% might be a reflection of a highly motivated
cohort, with implications for the external validity of our find-
ings. Common reasons given for nonparticipation in the trial
included a reluctance of patients to agree to the 6-month time
commitment, no guarantee of a positive outcome, living too
far away from the center and/or transport difficulties, and lack
of financial reimbursement for participation. It is unclear how
many of the nonparticipating patients engaged in an unsuper-
vised exercise program.
As reported previously, upper-limb aerobic exercise
Table IV. Continued.
48 weeks
Mean difference
(95% CI) P
7.49 (–0.03 to 15.02) .051
3.83 (–2.95 to 10.61) .263
–0.36 (–13.07 to 12.36) .955
8.02 (–2.39 to 18.44) .129
7.30 (–1.68 to 16.28) .109
7.14 (–2.28 to 16.56) .135
5.78 (–1.22 to 12.78) .104
5.40 (–1.14 to 11.94) .104
8.02 (1.30 to 14.74) .020b
6.31 (–0.14 to 12.76) .055
4.05 (–8.08 to 16.18) .507
5.19 (–6.25 to 16.63) .368
5.52 (–5.73 to 16.76) .331
6.22 (–4.67 to 17.11) .259
5.01 (–1.54 to 11.56) .131
–2.91 (–10.58 to 4.76) .452
LLG, Lower-limb group; ULG, upper-limb group.
aNegative mean difference value indicates lower than the control group.
bP value indicates significant difference from the control group.training evoked a similar improvement in walking perfor- aance and lower-limb peak oxygen consumption as did
ower-limb aerobic exercise training.21,22 Central and sys-
emic cardiovascular adaptations (rather than localized
keletal muscle metabolic adaptations) are likely to have
nderpinned the improvements in walking performance in
he upper-limb exercisers.22,30 Although the intensity of
xercise was precisely controlled on the basis of limb-
pecific peak oxygen consumption, in practice, exercise
ntensities of 12 to 14 (“somewhat hard”) on the Borg
atings of Perceived Exertion scale23 are sufficient to evoke
uch improvements. It is likely that such a supervised exer-
ise regimen could be implemented inexpensively, taking
nto account the costs of the arm-cranking devices and the
ime of an exercise specialist or physical therapist. Further
tudies are needed to evaluate the relative effect and cost-
ffectiveness of unsupervised programs.
A full understanding of the health benefits resulting
rom exercise rehabilitation cannot be gleaned exclusively
rom objective laboratory testing, and patient-centered health
utcomes are also needed to assess the effect on daily physical
unctioning and health-related QOL. Scores for the WIQ
omains were similar to those reported previously for patients
ith intermittent claudication12,26,29,31; however, baseline
cores for the SF-36v2 domains of physical function, bodily
ain, and general health were lower for our patient cohort
ompared with published population norms for people with-
ut intermittent claudication.32 Scores for all the other do-
ains were comparable with normative data.
Short-term changes (12 weeks) in health-related
uality QOL domains during programs of exercise training
ave not been extensively studied in this patient popula-
ion. However, this could provide important information
72 weeks
Mean difference
(95% CI) P
7.86 (1.14 to 14.58) .023b
5.00 (–1.25 to 11.24) .115
4.93 (–5.13 to 14.99) .330
10.98 (2.59 to 19.38) .011b
10.01 (1.93 to 18.08) .016b
6.73 (–2.33 to 15.78) .143
7.94 (0.65 to 15.22) .033b
9.40 (3.08 to 15.73) .004b
9.77 (2.84 to 16.69) .006b
5.65 (–1.55 to 12.85) .122
11.07 (–0.49 to 22.62) .060
7.39 (–3.98 to 18.76) .199
9.69 (–1.11 to 20.50) .078
9.09 (–1.46 to 19.65) .090
8.35 (1.26 to 15.44) .022b
4.53 (–3.06 to 12.13) .238bout the efficacy of such treatment interventions because
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exercise rehabilitation. Improvements in the WIQ domains
of claudication severity and stair climbing ability were ob-
served in the ULG in relation to controls. However, no
changes were noted in the LLG, in which improvements
were limited to the general health domain of the SF-36v2.
Although it is difficult to explain the different short-term
responses in the two exercise groups, some patients can
exercise at relatively higher aerobic intensities during upper-
limb aerobic exercise,20 which could act as a more potent
stimulus for cardiovascular adaptations.
We have recently shown that upper-limb aerobic exer-
cise training evokes cardiovascular adaptations that en-
hance lower-limb oxygen delivery during submaximal
walking exercise in claudicants.33 Also, stair climbing is an
activity that often uses the arms for stability, and this might
account for the observed improvement in perceived stair
climbing ability in the ULG.
Only one previous study has investigated changes in
SF-36 QOL domains after a 6-week program of similar
arm-cranking and leg-cranking exercise training in claudi-
cants.21 In this study, improvements in the physical func-
tioning and role (limitation)–physical domains were ac-
companied by more pronounced changes in walking
performance. This might account for the difference in
results between studies.
After 24 weeks, improvements in disease-specific func-
tional status, as indicated by the WIQ, were observed in
both exercising groups but with more pronounced changes
observed for perceived walking distance in the ULG. The
observed improvements in WIQ domains were similar to
those that have previously reported for claudication sever-
ity, distance, and speed after programs of treadmill walking
exercise lasting 12 to 24 weeks in some studies.11,12,34 This
shows that alternative, relatively pain-free exercise modali-
ties such as arm-cranking can evoke improvements in per-
ceived lower-limb functional status that are comparable to
the changes observed after programs of more painful lower-
limb weight-bearing exercise.
After 24 weeks, more consistent and pronounced
changes in SF-36v2 generic health-related QOL domains
were also observed in the ULG. Upper-limb aerobic exer-
cise evoked improvements in the physical function, bodily
pain, general health, vitality, and mental health domains of
the SF-36v2, whereas improvements were limited to the
physical function and general health domains in the LLG.
Positive changes in the physical functioning12-16 and bodily
pain15,16 domains of generic QOL instruments have been
reported previously after programs of lower-limb exercise
training in claudicants, whereas increases in the mental
health domains are not usually apparent.13,14,35
An interesting finding was that at 24 to 72 weeks of
follow-up, the observed improvements in disease-specific
and generic health-related QOL outcomes were generally
maintained in both exercising groups. Equivalent increases
in objective measures of walking performance were also
observed, which makes it unlikely that the more consistent
and pronounced generic health benefits of upper-limb ex- Frcise training were exclusively influenced by changes in
alking ability. Previous research has shown that health-
elated QOL is only partially determined by ambulatory
ysfunction in claudicants36 and that impairments in men-
al and emotional well-being in this patient group are not
elated to the severity of claudication.7,8 In addition, co-
orbid conditions such as hypertension, angina, hypercho-
esterolemia, diabetes, osteoarthritis, and pulmonary dis-
ase, all of which are common in claudicants,17 significantly
ffect most aspects of QOL.36 Hence, exercise training
odalities that can significantly affect central and systemic
ardiovascular function or that can help to alleviate the
urden of concomitant disease(s) could have a strong bear-
ng on perceived health-related QOL.
Furthermore, evidence suggests that arm-cranking
xercise provides a more effective stimulus than comparable
ower-limb exercise training for evoking systemic anti-
nflammatory adaptations in patients with intermittent
laudication,37 and this could have a positive effect on
ardiovascular morbidity andmortality.38 Improvements in
pper-body strength and endurance evoked by arm-cranking
xercise could also significantly affect the execution of normal
aily activities, hence reflecting positively in a wider range
f generic health-related QOL domains.
ONCLUSIONS
Improvements in patient perceptions of disease-specific
unctional status and generic health-related QOL domains
ere observed after both the upper-limb and lower-limb
xercise training regimens. After 6 weeks of exercise training,
imited changes were apparent, and after 24 to 72 weeks of
ollow-up, improvements were more pronounced in the
LG. Both forms of exercise training were well tolerated;
owever, because upper-limb exercise training avoids the isch-
mic pain that is experienced during lower-limb exertion,20 it
ould be used in the early stages of an exercise rehabilitation
rogram until patients feel more able and confident to engage
n lower-limb exercise. It might also be a preferred exercise
ption for patients with increased disease severity. Contrain-
ications to this form of exercise training include painful
pper-limb arthritis and other musculoskeletal conditions af-
ecting the arms or grip strength.
Nevertheless, themore pronounced changes in patient-
entered physical and mental health outcomes after arm-
ranking exercise training, together with previously re-
orted evidence of improved functional status and systemic
nti-inflammatory adaptations,21,30,37 provide further sup-
ort for the role of alternative relatively pain-free forms of
xercise training in the clinical management of patients
ith symptomatic peripheral arterial disease.
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